MMF Influence on HCV Viral Evolution After Liver Transplantation

Mayo Clinic

Status: Completed

Conditions: Liver Transplantation; HCV Infection

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT00170131

CEL358

1801-02

Details and patient eligibility

About

Samples from a large clinical trial comparing three immunosuppression regimens, two of which contained MMF, are used to identify the HCV viral quasispecies behaviour after liver transplantation

Enrollment: 17 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

All patients enrolled into - An Open Randomized, Prospective Multicenter Study to Compare the Efficacy and Safety Among Three Immunosuppressant Treatment Regimens in Patients Receiving a Liver Transplant for End-Stage Liver Disease Caused by Chronic Hepatitis C Infection